Overview

Safety and Efficacy Study of Paliperidone Extended Release (ER) Among Thai Schizophrenia Participants

Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effectiveness and safety of paliperidone extended release (ER) treatment in Thai schizophrenia (psychiatric disorder with symptoms of emotional instability, detachment from reality, often with delusions and hallucinations, and withdrawal into the self) participants.
Phase:
Phase 4
Details
Lead Sponsor:
Janssen-Cilag Ltd.,Thailand
Treatments:
Paliperidone Palmitate